These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 641718)

  • 21. Approaches to reducing subvisible particle counts in lyophilized parenteral formulations.
    Gupta PK; Porembski E; Williams NA
    J Pharm Sci Technol; 1994; 48(1):30-7. PubMed ID: 8004415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Particulate contamination in parenteral nutrition solutions: still a cause for concern?
    Ball PA; Bethune K; Fox J; Ledger R; Barnett M
    Nutrition; 2001; 17(11-12):926-9. PubMed ID: 11744342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative analysis of particulate matter in infusion solutions, administration sets and additives (author's transl)].
    Ahnefeld FW; Klaus E
    Anaesthesist; 1977 Aug; 26(8):476-84. PubMed ID: 907081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New cleanliness assessement for particulate matters in large-volume parenteral injection].
    Tsuji S; Isaka H
    Yakugaku Zasshi; 1987 Mar; 107(3):238-44. PubMed ID: 3598875
    [No Abstract]   [Full Text] [Related]  

  • 25. Particulate matter determination in LVPs produced in Dutch hospital pharmacies, Part 1: Particle-counting accuracy.
    Van der Veen J; Verbrugge P; Van de Vaart FJ; Boom FA
    PDA J Pharm Sci Technol; 1997; 51(2):81-8. PubMed ID: 9146039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particulate matter in small-volume parenterals as determined by two methods.
    Lim YS; Turco S; Davis NM
    Am J Hosp Pharm; 1973 Jun; 30(6):518-25. PubMed ID: 4709933
    [No Abstract]   [Full Text] [Related]  

  • 29. Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis.
    van den Berg RB; Ganesh M; Crul M; Wilms EB; Swart EL; Westerman EM
    J Pharm Sci; 2024 Sep; 113(9):2668-2674. PubMed ID: 38852673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field evaluation of nanofilm detectors for measuring acidic particles in indoor and outdoor air.
    Cohen BS; Heikkinen MS; Hazi Y; Gao H; Peters P; Lippmann M
    Res Rep Health Eff Inst; 2004 Sep; (121):1-35; discussion 37-46. PubMed ID: 15553489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential hazard of particulate contamination of cardioplegic solutions.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 33. Particulate matter determination in LVPs produced in Dutch hospital pharmacies. Part 2: Overview of the results.
    Boom FA; Van der Veen J; Verbrugge P; Van de Vaart FJ; Paalman AC; Vos T
    PDA J Pharm Sci Technol; 2000; 54(4):343-58. PubMed ID: 10969531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-destructive optical screening method for particulate matter in intravenous solutions.
    Passl WJ; Rumsey N; Trotter A
    Analyst; 1980 May; 105(1250):512-5. PubMed ID: 7396221
    [No Abstract]   [Full Text] [Related]  

  • 35. Particulate contamination of sterile syringes and needles.
    Taylor SA
    J Pharm Pharmacol; 1982 Aug; 34(8):493-5. PubMed ID: 6126558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Particulate matter in four reconstituted cephalosporin injections.
    Kilarski DJ; Visconti JA; Frank SG
    Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cleanliness assessment of supplier-cleaned stoppers.
    Townsend MW; Conti B; Hazrati A; DeLuca PP
    J Parenter Sci Technol; 1989; 43(2):98-102. PubMed ID: 2709242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An improvement on the power law for the description of particle size distributions in potable water treatment.
    Ceronio AD; Haarhoff J
    Water Res; 2005; 39(2-3):305-13. PubMed ID: 15644239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photoinduced particulate matter in a parenteral formulation for bisnafide, an experimental antitumor agent.
    Rubino JT; Chan LL; Walker JT; Segretario J; Everlof JG; Hussain MA
    Pharm Dev Technol; 1999 Aug; 4(3):439-47. PubMed ID: 10434290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Particle contamination in a ternary nutritional admixture.
    Foroni LA; Rochat MH; Trouiller P; Calop JY
    J Parenter Sci Technol; 1993; 47(6):311-4. PubMed ID: 8120737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.